Zevra to Present Data from KP1077 Phase 2 Trial in IH at SLEEP
Zevra's CEO updates shareholders on recent milestones, including the completion of a phase 2 trial for idiopathic hypersomnia.
Source: sleepreviewmag.com
Stay updated with breaking news from One Zevra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zevra's CEO updates shareholders on recent milestones, including the completion of a phase 2 trial for idiopathic hypersomnia.